OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-11-30-accounts

Company Registration Number. SC492045 (Scotland)

Fibromyalgia Action UK Unaudited financial statements and annual report For the year ended 30 November 2020

Fibromyalgia Action UK Contents

For the year ended 30 November 2020

CONTENTS PAGE
Company Information 3
Director's Report 4
Accountant's Report 5
Income Statement 6
Statement of Financial Position 7
Notes to the Financial Statements 8 ­ 9
Detailed Income Statement 10

Fibromyalgia Action UK Company Information For the year ended 30 November 2020

Company registration number SC492045 (Scotland) Directors who served during the year Glen Mcgregor Registered office address 12 Seedhill Road 3007 Mile End Mill Paisley PA1 1JS Accountant J Botham T and Acc Ltd Director Archer House, Britl Est Northbourne Road BN22 8PW

Fibromyalgia Action UK Director's Report

For the year ended 30 November 2020

The director presents the annual report and the Unaudited Financial Statement for the year ended 30 November 2020.

Principal activity

The principal activity of the company continued to be that of provision of support and awareness of fibromyalga sufferers.

Going concern

The financial statements have been prepared on a going concern basis unless it is inappropriate to presume that the company will continue in business.

Director of the company

The following directors held office during the whole of the period: Glen Mcgregor

Statement of director's responsibilities

The directors are responsible for preparing the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare such financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), FRS 102 1A.

Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to;

select suitable accounting policies and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Small company provisions

This report has been prepared in accordance with the special provisions for small companies within Part 15 of the Companies Act 2006.

Approved by the Board of directors and signed on its behalf by:

Glen McGregor (Director) Date: 09 April 2021

Fibromyalgia Action UK Accountant's report For the year ended 30 November 2020

Accountant's Report to the board of directors on the preparation of the unaudited statutory accounts of Fibromyalgia Action UK for the year ended 30 November 2020.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Fibromyalgia Action UK for the year ended 30 November 2020.

We have prepared these financial statements based on the accounting records, information and explanations provided by you. We do not express any opinion on these financial statements.

On the Statement of Financial Position, you have acknowledged your duties under the prevailing Companies Act 2006 that the company keeps adequate accounting records and prepares financial statements that give "a true and fair view".

You have determined that the company is exempt from the statutory requirement for an audit for this accounting year. Therefore, the financial statements are unaudited.

The financial statements are provided exclusively to the director for the limited purpose mentioned above, and may not be used or relied upon for any other purpose or by any other person, and we shall not be liable for any other usage or reliance.

J Botham T and Acc Ltd Director Archer House, Britl Est Northbourne Road BN22 8PW Date: 09 April 2021

Fibromyalgia Action UK Income Statement For the year ended 30 November 2020

Notes
Turnover
2
Cost of raw materials and consumables
Gross profit
Selling and distribution expenses
Administrative expenses
Other operating income
Operating loss
3
Interest receivable and similar income
Loss on ordinary activities before taxation
Loss for the year		 2020
£
2,834
(1,239)
1,595
(963)
(108,778)
104,818
(3,328)
196
(3,132)
(3,132)		 2019
£
425
(2,469)
(2,044)
(3,272)
(87,655)
124,024
31,054
282
31,335
31,335

Fibromyalgia Action UK Statement of Financial Position

For the year ended 30 November 2020

Notes
Fixed assets
Property, plant and equipment
5
Current assets
Inventories
6
Debtors
7
Corporation tax receivable
Cash and cash equivalents
8
Current liabilities
Creditors: Amounts falling due within one year
9
Net current assets/(liabilities)
Total assets less current liabilities
Net assets/(liabilities)
Capital and reserves
Retained earnings
Shareholder's funds		 2020
£
590
590
2,420
6,041
58
281,118
289,637
(194)
(194)
289,443
290,033
290,033
290,033
290,033		 2019
£
590
590
2,420
7,230
­
284,369
294,019
(1,444)
(1,444)
292,575
293,165
293,165
293,165
293,165

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A ­ Small Entities.

Approved by the Board on 09 April 2021

............................. Glen McGregor (Director) Company registration number: SC492045

Fibromyalgia Action UK Notes to the Financial Statements

For the year ended 30 November 2020

(1) General Information

Fibromyalgia Action UK is a private company limited by shares, domiciled and incorporated in England and Wales. Its registered office is 12 Seedhill Road, 3007 Mile End Mill, Paisley, PA1 1JS.

(2) Turnover

The revenue from company's operations comprise:

Sales
) Operating profit
Operating profit for the year from continuing operations has been arrived after charging:
Depreciation of property, plant and equipment
Staff costs		 2020
£
2,834
2,834
2020
£
­
75,139
75,139		 2019
£
425
425
2019
£
197
52,160
52,356

(3) Operating profit

(4) Employees

During the year, the average number of employees including director was 0 (2019 : 0) The above numbers are averages for the year and calculated on a full­time equivalent basis. The aggregate payroll costs of the above were:

Wages and salaries
Social security cost		 2020
£
69,938
3,210
73,147		 2019
£
50,981
832
51,813

(5) Tangible fixed assets

Cost
As at 01 December 2019
As at 30 November 2020
Depreciation
As at 01 December 2019		 Fixtures and Fittings
£
5,215		 Totals
£
5,215
5,215 5,215
4,626 4,626
As at 30 November 2020
Net book value
As at 30 November 2019
(6) Inventories
Stock of finished goods
(7) Trade and other receivables
Amounts falling due within one year
Trade debtors
Other debtors
Prepayments and accrued income
(8) Cash and cash equivalents
Bank balance
(9) Trade and other payables
Trade creditors
Accruals and deferred income
(10) Called up share capital and reserves
Called up and fully paid:
100 Ordinary shares of £1 each		 4,626 4,626
590
589
2019
£
2,420
2,420
2019
£
7,198
­
32
7,230
2019
£
284,369
284,369
2019
£
1,368
76
1,444
2019
£
­
590
589
2020
£
2,420
2,420
2020
£
294
3,979
1,768
6,041
2020
£
281,118
281,118
2020
£
­
194
194
2020
£
­

Fibromyalgia Action UK Notes to the financial statements (Continued) For the year ended 30 November 2020

Retained earnings 2020
£
At 1 December 2019 293,165
Loss of the year (3,132)
At 30 November 2020 290,033

Fibromyalgia Action UK Detailed Income Statement For the year ended 30 November 2020

Turnover
Less : Cost of raw materials and consumables
Other direct expenses
Purchases
Transportation cost
Closing stock
Opening stock
Gross Profit
Add : Other operating income
Charities Aid Foundation Income
Donations Received
Fundraising Income
Non taxable income
Payroll Income
Less : Selling and distribution expenses
Advertising, sales promotion, marketing
Trustee Expenses
Volunteer Expenses
Travel and overseas travelling
Less : Administrative expenses
Accountancy fee
Bank, card and overdraft charges
Computer cost
Employee Salary expense
Employer NI
Equipment maintenance, rental and leasing
Insurance
Membership and subscriptions
Office Rental
Pension Contributions
Postage, stationery, office supplies
Professional, consultancy and legal fees
Sundry expenses
Telephone, internet and broadband
Training and development
Depreciation of fixtures and fittings
Rates
Operating loss
Add : Interest receivable and similar income
Bank interest receivable
loss on ordinary activities before taxation
Net loss for the year after taxation
Net loss for the year after dividends
Retained profits brought forward
Retained profits carried forward		 2020
£
2,834
435
694
110
­
­
1,239
1,595
155
58,973
478
44,947
266
104,818
66
637
260
­
963
300
260
498
69,938
3,210
1,533
107
1,467
24,329
1,991
2,025
1,991
58
1,461
(390)
­
­
108,778
(3,328)
196
196
(3,132)
(3,132)
(3,132)
293,165
290,033		 2019
£
425
1,474
1,099
(104)
(2,420)
2,420
2,469
(2,044)
55
110,090
11,668
2,000
211
124,024
1,365
1,067
242
598
3,272
300
928
­
50,981
832
­
2,087
1,522
13,539
347
10,422
1,222
­
4,725
226
196
327
87,655
31,054
282
282
31,335
31,335
31,335
261,829
293,165

This section does not form part of company's statutory financial statements.